NEW YORK (GenomeWeb News) – Roche announced today that the Neuromuscular Disorder-Chip Consortium has selected Roche NimbleGen microarrays for its genetic research on neuromuscular disorders (NMDs).

The researchers will use custom-designed NimbleGen Human CGH 12x135K microarrays to look for NMD-related gene and exon level rearrangements, deletions, or insertions — particularly for NMDs such as Duchenne/Becker muscular dystrophies, limb girdle muscular dystrophies, congenital muscular dystrophies, hereditary motor-sensory neuropathies, and Charcot-Marie-Tooth neuropathies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.